Artax Biopharma
Executives
6Board of Directors
1Artax Biopharma Board of Director
1 Board of directors
Artax Biopharma has 1 board of directors, including Alan Walts.
Name | Firm | Work History | Other Seats |
|---|---|---|---|
Alan Walts | Dr. Walts is a Board Observer and Advisor to Amylyx. Alan has broad experience in the Life Science industry and serves as Executive Chairman of Aura Biosciences, Executive Chairman of Artax Biopharma, as a Director of X4 Pharmaceuticals and as a Director of Arrakis Therapeutics. Alan was a Business Advisor to the late Henri Termeer, and worked closely with Henri on founding and investing in early-stage companies. Alan is also a US-based Venture Partner with Advent Life Sciences. Alan has over 25 years of industry experience in venture capital, business development, research and development, and general management at Genzyme Corporation. Prior to leaving Genzyme in 2013, Alan managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi-Genzyme BioVentures). Alan received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the Executive Program for Management Development at Harvard Business School. | Artax Biopharma |
Name | Alan Walts |
|---|---|
Firm | |
Work History | Dr. Walts is a Board Observer and Advisor to Amylyx. Alan has broad experience in the Life Science industry and serves as Executive Chairman of Aura Biosciences, Executive Chairman of Artax Biopharma, as a Director of X4 Pharmaceuticals and as a Director of Arrakis Therapeutics. Alan was a Business Advisor to the late Henri Termeer, and worked closely with Henri on founding and investing in early-stage companies. Alan is also a US-based Venture Partner with Advent Life Sciences. Alan has over 25 years of industry experience in venture capital, business development, research and development, and general management at Genzyme Corporation. Prior to leaving Genzyme in 2013, Alan managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi-Genzyme BioVentures). Alan received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the Executive Program for Management Development at Harvard Business School. |
Other Seats | Artax Biopharma |
Artax Biopharma Management Team
6 Team Members
Artax Biopharma has 6 executives. Artax Biopharma's founder is Damia Tormo. Artax Biopharma's current Chief Executive Officer is Joseph M. Lobacki.
Name | Work History | Title | Status |
|---|---|---|---|
Damia Tormo | Founder | Current | |
Joseph M. Lobacki | Chief Executive Officer | Current | |
Andrés Gagete Mateos | Chief Operating Officer | Current | |
Richard Polisson | Chief Medical Officer | Current | |
Victor Vercher | Touchlight AAV, Columbus Venture Partners, DiningIn, Suffolk University, and Root Capital | Chief Financial Officer | Former |
Name | Damia Tormo | Joseph M. Lobacki | Andrés Gagete Mateos | Richard Polisson | Victor Vercher |
|---|---|---|---|---|---|
Work History | Touchlight AAV, Columbus Venture Partners, DiningIn, Suffolk University, and Root Capital | ||||
Title | Founder | Chief Executive Officer | Chief Operating Officer | Chief Medical Officer | Chief Financial Officer |
Status | Current | Current | Current | Current | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.